From: Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
AMC MIC
N (%)
FOX MIC
TZP MIC
4
19 (21.8)
<=4
60 (72.3)
65 (70.7)
8
19.0 (21.8)
6 (7.2)
8.0
27.0 (29.3)
16
32 (36.8)
8 (9.6)
-
> = 32
17 (19.5)
32
9 (10.8)
> = 64
Total
87
83
92